Astex Pharmaceuticals Inc (NASDAQ:ASTX)
| 5.36 Data as of May 24 |  +0.24 / +4.69%Today’s Change | 1.62 Today|||52-Week Range 6.95 | +84.19% Year-to-Date |
Latest ASTX News | Press Releases
No recent news for Astex Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.12 |
| Today’s open | 5.11 |
| Day’s range | 5.05 - 5.45 |
| Volume | 640,922 |
| Average volume (3 months) | 1,751,843 |
| Market cap | $507.1M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -500.00% |
| Earnings growth (next 5 years) | +23.90% |
| Revenue growth (last year) | +24.28% |
| P/E ratio | 134.0 |
| Price/Sales | 3.26 |
| Price/Book | 2.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ECYTEndocyte Inc | 0.00 | 0.00% |
| EBSEmergent BioSolution... | -0.10 | -0.70% |
| SPPISpectrum Pharmaceuti... | -0.22 | -2.57% |
| MACKMerrimack Pharmaceut... | -0.06 | -1.14% |
Data as of 4:02pm ET, 05/24/2013
Financials
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $83.2M |
| Annual profit (last year) | $8.2M |
| Net profit margin | 9.92% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer James S. J. Manuso, PhD, MBA |
President & Director Harren Jhoti, PhD |
Corporate headquarters Dublin, California |
Forecasts
